Theravance Inc (NASDAQ:THRX)

16.46
Delayed Data
As of Mar 27
 -0.13 / -0.78%
Today’s Change
10.58
Today|||52-Week Range
31.80
+16.33%
Year-to-Date

Today’s Trading

Previous close16.59
Today’s open16.61
Day’s range16.21 - 16.82
Volume400,385
Average volume (3 months)994,332
Market cap$1.9B
Dividend yield6.08%
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+92.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.70+2.51%
INSYINSYS Therapeutics I...+0.44+0.79%
RAREUltragenyx Pharmaceu...+2.39+4.41%
PTCTPTC Therapeutics Inc+2.15+3.56%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account